Risk Factors for Contralateral Occult Papillary Thyroid Carcinoma in Patients with Clinical Unilateral Papillary Thyroid Carcinoma: A Case-Control Study
Introduction. Papillary thyroid cancer (PTC) is one of the most prevalent endocrine malignancies that has increased in recent decades around the world. Although the indicator for navigating the surgical extent in PTC patients is still in debate, a key issue is how to predict that there are undetecte...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2022/5112985 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832565639786528768 |
|---|---|
| author | Liu Yihao Li Shuo Xi Pu Wang Zipeng Sun Hanlin Chang Qungang Wang Yongfei Yin Detao |
| author_facet | Liu Yihao Li Shuo Xi Pu Wang Zipeng Sun Hanlin Chang Qungang Wang Yongfei Yin Detao |
| author_sort | Liu Yihao |
| collection | DOAJ |
| description | Introduction. Papillary thyroid cancer (PTC) is one of the most prevalent endocrine malignancies that has increased in recent decades around the world. Although the indicator for navigating the surgical extent in PTC patients is still in debate, a key issue is how to predict that there are undetected preoperative tumors in the contralateral thyroid lobe. This study aims to find risk factors for contralateral occult papillary thyroid cancer (COPTC) to facilitate more accurate surgical decisions made for patients with PTC. Materials and Methods. In our study, we included 229 patients who underwent total thyroidectomy plus central and ipsilateral lateral lymph nodes dissection from January 1, 2019, to September 1, 2021. Univariate and multivariate logistic regression analyses were conducted to assess the association between COPTC and clinical-pathological characteristics, as well as the relation between the diameter of the occult lesions and predictors. The forest plot was plotted to visualize the prediction factors from the output of the multivariate regression analysis. A ROC curve was used to evaluate the combining potency of all the risk factors. Results. Of the 229 patients included in our study, 46 with COPTC were assigned to the case group, representing 20.1% in this study. Multifocality in one lobe (OR = 2.21, P=0.03), intact capsule (OR = 2.54, P=0.01), central lymph node metastasis (OR = 3.00, P=0.02), and Hashimoto’s thyroiditis (OR = 2.08, P = 0.04) are more prone to present contralateral occult papillary thyroid carcinoma. The ROC curve of the aggregate potency of the risk factors presents AUC = 0.701 (P<0.001), and the best cutoff value was 2.02, with a sensitivity of 78.3% and specificity of 55.2%. Furthermore, there was no statistical correlation between the diameter of the occult tumor and the four obtained variables. Conclusion. Patients with multifocality in one lobe, intact capsule, central lymph node metastasis, and HT may harbor contralateral papillary thyroid carcinoma. It is essential to be prudent to make a surgical or follow-up decision on these patients. In addition, more clinical rather than postoperative pathological indicators need to be revealed in the future. |
| format | Article |
| id | doaj-art-3db3b86ac6ee4526bd82dc8565fb3a49 |
| institution | Kabale University |
| issn | 1687-8345 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Endocrinology |
| spelling | doaj-art-3db3b86ac6ee4526bd82dc8565fb3a492025-02-03T01:07:05ZengWileyInternational Journal of Endocrinology1687-83452022-01-01202210.1155/2022/5112985Risk Factors for Contralateral Occult Papillary Thyroid Carcinoma in Patients with Clinical Unilateral Papillary Thyroid Carcinoma: A Case-Control StudyLiu Yihao0Li Shuo1Xi Pu2Wang Zipeng3Sun Hanlin4Chang Qungang5Wang Yongfei6Yin Detao7Thyroid Surgery DepartmentThyroid Surgery DepartmentThyroid Surgery DepartmentThyroid Surgery DepartmentThyroid Surgery DepartmentThyroid Surgery DepartmentThyroid Surgery DepartmentThyroid Surgery DepartmentIntroduction. Papillary thyroid cancer (PTC) is one of the most prevalent endocrine malignancies that has increased in recent decades around the world. Although the indicator for navigating the surgical extent in PTC patients is still in debate, a key issue is how to predict that there are undetected preoperative tumors in the contralateral thyroid lobe. This study aims to find risk factors for contralateral occult papillary thyroid cancer (COPTC) to facilitate more accurate surgical decisions made for patients with PTC. Materials and Methods. In our study, we included 229 patients who underwent total thyroidectomy plus central and ipsilateral lateral lymph nodes dissection from January 1, 2019, to September 1, 2021. Univariate and multivariate logistic regression analyses were conducted to assess the association between COPTC and clinical-pathological characteristics, as well as the relation between the diameter of the occult lesions and predictors. The forest plot was plotted to visualize the prediction factors from the output of the multivariate regression analysis. A ROC curve was used to evaluate the combining potency of all the risk factors. Results. Of the 229 patients included in our study, 46 with COPTC were assigned to the case group, representing 20.1% in this study. Multifocality in one lobe (OR = 2.21, P=0.03), intact capsule (OR = 2.54, P=0.01), central lymph node metastasis (OR = 3.00, P=0.02), and Hashimoto’s thyroiditis (OR = 2.08, P = 0.04) are more prone to present contralateral occult papillary thyroid carcinoma. The ROC curve of the aggregate potency of the risk factors presents AUC = 0.701 (P<0.001), and the best cutoff value was 2.02, with a sensitivity of 78.3% and specificity of 55.2%. Furthermore, there was no statistical correlation between the diameter of the occult tumor and the four obtained variables. Conclusion. Patients with multifocality in one lobe, intact capsule, central lymph node metastasis, and HT may harbor contralateral papillary thyroid carcinoma. It is essential to be prudent to make a surgical or follow-up decision on these patients. In addition, more clinical rather than postoperative pathological indicators need to be revealed in the future.http://dx.doi.org/10.1155/2022/5112985 |
| spellingShingle | Liu Yihao Li Shuo Xi Pu Wang Zipeng Sun Hanlin Chang Qungang Wang Yongfei Yin Detao Risk Factors for Contralateral Occult Papillary Thyroid Carcinoma in Patients with Clinical Unilateral Papillary Thyroid Carcinoma: A Case-Control Study International Journal of Endocrinology |
| title | Risk Factors for Contralateral Occult Papillary Thyroid Carcinoma in Patients with Clinical Unilateral Papillary Thyroid Carcinoma: A Case-Control Study |
| title_full | Risk Factors for Contralateral Occult Papillary Thyroid Carcinoma in Patients with Clinical Unilateral Papillary Thyroid Carcinoma: A Case-Control Study |
| title_fullStr | Risk Factors for Contralateral Occult Papillary Thyroid Carcinoma in Patients with Clinical Unilateral Papillary Thyroid Carcinoma: A Case-Control Study |
| title_full_unstemmed | Risk Factors for Contralateral Occult Papillary Thyroid Carcinoma in Patients with Clinical Unilateral Papillary Thyroid Carcinoma: A Case-Control Study |
| title_short | Risk Factors for Contralateral Occult Papillary Thyroid Carcinoma in Patients with Clinical Unilateral Papillary Thyroid Carcinoma: A Case-Control Study |
| title_sort | risk factors for contralateral occult papillary thyroid carcinoma in patients with clinical unilateral papillary thyroid carcinoma a case control study |
| url | http://dx.doi.org/10.1155/2022/5112985 |
| work_keys_str_mv | AT liuyihao riskfactorsforcontralateraloccultpapillarythyroidcarcinomainpatientswithclinicalunilateralpapillarythyroidcarcinomaacasecontrolstudy AT lishuo riskfactorsforcontralateraloccultpapillarythyroidcarcinomainpatientswithclinicalunilateralpapillarythyroidcarcinomaacasecontrolstudy AT xipu riskfactorsforcontralateraloccultpapillarythyroidcarcinomainpatientswithclinicalunilateralpapillarythyroidcarcinomaacasecontrolstudy AT wangzipeng riskfactorsforcontralateraloccultpapillarythyroidcarcinomainpatientswithclinicalunilateralpapillarythyroidcarcinomaacasecontrolstudy AT sunhanlin riskfactorsforcontralateraloccultpapillarythyroidcarcinomainpatientswithclinicalunilateralpapillarythyroidcarcinomaacasecontrolstudy AT changqungang riskfactorsforcontralateraloccultpapillarythyroidcarcinomainpatientswithclinicalunilateralpapillarythyroidcarcinomaacasecontrolstudy AT wangyongfei riskfactorsforcontralateraloccultpapillarythyroidcarcinomainpatientswithclinicalunilateralpapillarythyroidcarcinomaacasecontrolstudy AT yindetao riskfactorsforcontralateraloccultpapillarythyroidcarcinomainpatientswithclinicalunilateralpapillarythyroidcarcinomaacasecontrolstudy |